Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8713291 | Journal of Allergy and Clinical Immunology | 2018 | 38 Pages |
Abstract
CD3+TCRαβ+ and CD19+ cell-depleted haploidentical or mMUD HSCT is a practical and viable alternative for children with a range of PIDs.
Keywords
SCIDanti-thymocyte globulinGvHDHSCTHHV-6TPNmismatched unrelated donoraGVHDATGEFsTCrTMAPIDCTLnatural killerEvent-free survivalAcute graft-versus-host diseaseGraft-versus-host diseasecytomegalovirusCMVcytotoxic T lymphocyteHaploidenticalthrombotic microangiopathyHuman herpesvirus 6Hematopoietic stem cell transplantationTotal parenteral nutritionprimary immunodeficiencysevere combined immunodeficiencyT-cell receptor
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ravi M. MD, DRCPSC, Reem MD, Zohreh PhD, Waseem MD, PhD, Persis PhD, FRCP, FRCPath, Robert MD, Kanchan MRCPCH, Giovanna MD, Juliana M.F. MD, Austen MD, PhD, Dawn PhD, David DipSc, MSc, Jane MD, Andrew J. MD, Roderick PhD, DCH, FRCPCH, Intan Juliana MD,